Literature DB >> 16731291

The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III).

David Martins1, Naureen Tareen, Ashraf Zadshir, Deyu Pan, Roberto Vargas, Allen Nissenson, Keith Norris.   

Abstract

BACKGROUND: Albuminuria is a major risk factor for the development and progression of chronic kidney disease (CKD) and cardiovascular disease. Socioeconomic factors also have been reported to modify CKD and cardiovascular risk factors and clinical outcomes. The extent to which poverty influences the prevalence of albuminuria, particularly among racial/ethnic minority populations, is not well established. The influence of poverty on the prevalence of albuminuria and the implication of this relationship for the racial and/or ethnic differences in the prevalence of albuminuria were examined.
METHODS: We examined data from 6,850 male and 7,634 female adults from a national probability survey conducted between 1988 and 1994.
RESULTS: In univariate analysis, poverty, defined as less than 200% federal poverty level (FPL), was associated with the presence of both microalbuminuria (odds ratio [OR], 1.35; 95% confidence interval, 1.22 to 1.49) and macroalbuminuria (OR, 1.78; 95% confidence interval, 1.40 to 2.26). The association of less than 200% FPL with microalbuminuria persisted in a multivariate model controlling for age, sex, race, education, obesity, hypertension, diabetes, reduced glomerular filtration rate, and medication use (OR, 1.18; 95% confidence interval, 1.05 to 1.33). FPL less than 200% was not associated with macroalbuminuria in the multivariate model. When multivariate analysis is stratified by FPL (<200% and > or =200%), differences in ORs for microalbuminuria and macroalbuminuria among racial/ethnic minority participants compared with whites were more apparent among the less affluent participants in the FPL-less-than-200% stratum.
CONCLUSION: FPL less than 200% is associated with microalbuminuria, and differences in FPL levels may account for some of the observed differences in prevalence of albuminuria between racial/ethnic minority participants and their white counterparts.

Entities:  

Mesh:

Year:  2006        PMID: 16731291      PMCID: PMC3863615          DOI: 10.1053/j.ajkd.2006.02.179

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  28 in total

1.  Childhood blood pressure predicts adult microalbuminuria in African Americans, but not in whites: the Bogalusa Heart Study.

Authors:  Sheikh Hoq; Wei Chen; Sathanur R Srinivasan; Gerald S Berenson
Journal:  Am J Hypertens       Date:  2002-12       Impact factor: 2.689

2.  Disparities in adolescent health and health care: does socioeconomic status matter?

Authors:  Paul W Newacheck; Yun Yi Hung; M Jane Park; Claire D Brindis; Charles E Irwin
Journal:  Health Serv Res       Date:  2003-10       Impact factor: 3.402

3.  Sample design: Third National Health and Nutrition Examination Survey.

Authors:  T M Ezzati; J T Massey; J Waksberg; A Chu; K R Maurer
Journal:  Vital Health Stat 2       Date:  1992-09

4.  Modifiable determinants of healthcare utilization within the African-American population.

Authors:  George Rust; George E Fryer; Robert L Phillips; Elvan Daniels; Harry Strothers; David Satcher
Journal:  J Natl Med Assoc       Date:  2004-09       Impact factor: 1.798

5.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

6.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

Authors:  Nagesh S Anavekar; John J V McMurray; Eric J Velazquez; Scott D Solomon; Lars Kober; Jean-Lucien Rouleau; Harvey D White; Rolf Nordlander; Aldo Maggioni; Kenneth Dickstein; Steven Zelenkofske; Jeffrey D Leimberger; Robert M Califf; Marc A Pfeffer
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

7.  Socioeconomic status and end-stage renal disease in the United States.

Authors:  E W Young; E A Mauger; K H Jiang; F K Port; R A Wolfe
Journal:  Kidney Int       Date:  1994-03       Impact factor: 10.612

8.  The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension.

Authors:  A A Lopes; K Hornbuckle; S A James; F K Port
Journal:  Am J Kidney Dis       Date:  1994-10       Impact factor: 8.860

9.  Income, income inequality, and cardiovascular disease mortality: relations among county populations of the United States, 1985 to 1994.

Authors:  Mark W Massing; Wayne D Rosamond; Steven B Wing; Chirayath M Suchindran; Berton H Kaplan; Herman A Tyroler
Journal:  South Med J       Date:  2004-05       Impact factor: 0.954

10.  Kidney disease in elderly minorities.

Authors:  Chamberlain I Obialo; Sharon Allison-Ottey
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

View more
  39 in total

1.  Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey.

Authors:  Orlando M Gutiérrez; Tamara Isakova; Gwen Enfield; Myles Wolf
Journal:  J Ren Nutr       Date:  2010-05-26       Impact factor: 3.655

2.  Poverty and racial disparities in kidney disease: the REGARDS study.

Authors:  William M McClellan; Britt B Newsome; Leslie A McClure; George Howard; Nataliya Volkova; Paul Audhya; David G Warnock
Journal:  Am J Nephrol       Date:  2010-05-31       Impact factor: 3.754

3.  Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.

Authors:  Paul Muntner; Suzanne E Judd; Marie Krousel-Wood; William M McClellan; Monika M Safford
Journal:  Am J Kidney Dis       Date:  2010-05-14       Impact factor: 8.860

4.  Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand.

Authors:  Sarah L White; Kevin McGeechan; Michael Jones; Alan Cass; Steven J Chadban; Kevan R Polkinghorne; Vlado Perkovic; Paul J Roderick
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

5.  Differences in albuminuria between Hispanics and whites: an evaluation by genetic ancestry and country of origin: the multi-ethnic study of atherosclerosis.

Authors:  Carmen A Peralta; Yongmei Li; Christina Wassel; Shweta Choudhry; Walter Palmas; Michael F Seldin; Neil Risch; David Siscovick; Donna Arnett; Bruce Psaty; Michael G Shlipak
Journal:  Circ Cardiovasc Genet       Date:  2010-05-05

Review 6.  Social Determinants of Racial Disparities in CKD.

Authors:  Jenna M Norton; Marva M Moxey-Mims; Paul W Eggers; Andrew S Narva; Robert A Star; Paul L Kimmel; Griffin P Rodgers
Journal:  J Am Soc Nephrol       Date:  2016-05-13       Impact factor: 10.121

Review 7.  Social Determinants of CKD Hotspots.

Authors:  Deidra C Crews; Tessa K Novick
Journal:  Semin Nephrol       Date:  2019-05       Impact factor: 5.299

8.  Effect of food insecurity on chronic kidney disease in lower-income Americans.

Authors:  Deidra C Crews; Marie Fanelli Kuczmarski; Vanessa Grubbs; Elizabeth Hedgeman; Vahakn B Shahinian; Michele K Evans; Alan B Zonderman; Nilka Rios Burrows; Desmond E Williams; Rajiv Saran; Neil R Powe
Journal:  Am J Nephrol       Date:  2014-01-08       Impact factor: 3.754

9.  Kidney disease and the cumulative burden of life course socioeconomic conditions: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  David A Shoham; Suma Vupputuri; Jay S Kaufman; Abhijit V Kshirsagar; Ana V Diez Roux; Josef Coresh; Gerardo Heiss
Journal:  Soc Sci Med       Date:  2008-07-28       Impact factor: 4.634

10.  Microalbuminuria in HIV disease.

Authors:  Colleen Hadigan; Elizabeth Edwards; Alice Rosenberg; Julia B Purdy; Estee Fleischman; Lilian Howard; JoAnn M Mican; Karmini Sampath; Akinbowale Oyalowo; Antoinette Johnson; Alexandra Adler; Catherine Rehm; Margo Smith; Leon Lai; Jeffrey B Kopp
Journal:  Am J Nephrol       Date:  2013-04-20       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.